Benign Prostatic Hyperplasia Research: Citation Impact and Public Attention

Benign prostatic hyperplasia (BPH) is a common condition affecting millions of men worldwide. According to editorial research analyzed by Groundwork, The medical literature on BPH is vast, with numerous studies published annually. However, not all BPH research receives equal attention from clinicians and patients. This article examines the citation impact and public attention of BPH research in the urological literature.

Research Context and Objectives

The objective of this study was to determine whether the most cited and the most publicly discussed BPH literature describe the same body of work. We also aimed to investigate whether clinicians and patients read different evidence.

Methodology and Study Design

In February 2024, we conducted four Boolean Web of Science searches and four matched Altmetric Explorer searches, restricted to literature indexed with urologic terminology. We screened the results in duplicate and assembled two arms: the 50 most-cited articles (citation census May 2024) and the 50 with the highest Altmetric Attention Scores.

We hand-coded the funding source and intervention focus from the full text of all 100 articles and obtained open-access status from Unpaywall. We compared the two arms using Mann-Whitney U and Fisher exact tests.

Key Findings and Data Analysis

Eight of 50 articles (16%) appeared in both arms. The citation-selected articles were older (median 2008 versus 2018, p<0.001), more often randomized trials (58% versus 22%, p<0.001), and more often published in urology-specific journals (96% versus 66%, p<0.001).

Industry funded 50% versus 18% of articles (p=0.001), and non-industry sources 8% versus 36% (p=0.001). Only 10% of citation-selected articles were open access versus 56% (p<0.001).

Attention data were recoverable for only 13 citation-selected articles (median score 9 versus 17). The two arms were cited in the 2026 AUA BPH Guideline at indistinguishable rates (22% versus 20%, p=1.00).

These findings suggest that the most cited and the most publicly discussed BPH literature are largely distinct bodies of work. The most significant separation between the two arms is whether the articles can be read without a subscription.

However, both bodies of work inform guideline development equally. Patients arrive with evidence systematically different from, and no less guideline-relevant than, that underpinning their urologist's training.

Implications

The results of this study have important implications for clinicians, patients, and researchers. Clinicians should be aware that the evidence they rely on may not be the same as the evidence their patients have accessed.

Patients should be empowered to critically evaluate the evidence they encounter and to seek out open-access resources. Researchers should prioritize open-access publication to ensure that their work is accessible to all stakeholders.

Recommendations

Based on the findings of this study, we recommend the following:

1. Prioritize open-access publication: Researchers should strive to publish their work in open-access journals to ensure that their findings are accessible to all stakeholders.
2. Develop open-access resources: Clinicians and patients should have access to open-access resources that provide accurate and unbiased information on BPH.
3. Critical evaluation of evidence: Patients should be empowered to critically evaluate the evidence they encounter and to seek out open-access resources.
4. Increased transparency: Researchers and clinicians should prioritize transparency in their research and clinical practices to ensure that patients have access to accurate and unbiased information.

---

Clinical Biomarker Tracking and Metabolic Energy Balance

Optimizing healthspan and physical performance requires objective biochemical tracking rather than relying on subjective energy sensations. Metabolic energy expenditure operates through three distinct compartments:

Total Daily Energy Expenditure (TDEE) = Basal Metabolic Rate (65-75%) + Thermic Effect of Food (10%) + Active Exercise / NEAT (15-25%)

Core Preventative Biomarker Evaluation Matrix

Clinical reference thresholds derived from the American Heart Association (AHA) and European Society of Cardiology (ESC) consensus guidelines.

Strategic Nutrition Architecture: Protein Sizing for Adults Over 35

To offset age-related sarcopenia (the gradual loss of skeletal muscle mass starting in the fourth decade), adults should target 1.6 to 2.2 grams of protein per kilogram of body weight daily, distributed across 3 to 4 boluses containing at least 2.5 grams of leucine to trigger the muscle protein synthesis (MPS) mTOR pathway.

---

Long-Term Physiological Risk and Recovery Architecture

1. Allostatic Load & Cortisol Management: Chronic psychological and physical stress elevates resting cortisol levels, blunting growth hormone release and impairing muscle protein synthesis. Integrate daily parasympathetic resets (box breathing, sauna, or active walking).
2. Sleep Architecture Preservation: Deep slow-wave sleep is the primary physiological window for cellular repair and glymphatic brain detoxification. Avoid late-night blue-light exposure, alcohol, and heavy meals within 3 hours of sleep onset.